FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,424,275 | -27.5% | 284,855 | +2.0% | 0.00% | -33.3% |
| Q2 2023 | $1,965,251 | +833.4% | 279,155 | +745.9% | 0.01% | +500.0% |
| Q4 2022 | $210,540 | -93.7% | 33,000 | -91.5% | 0.00% | -92.3% |
| Q3 2022 | $3,334,000 | -34.8% | 388,600 | +3.4% | 0.01% | -40.9% |
| Q2 2022 | $5,114,000 | +6373.4% | 376,000 | +7130.8% | 0.02% | – |
| Q1 2022 | $79,000 | -99.1% | 5,200 | -98.6% | 0.00% | -100.0% |
| Q4 2021 | $8,770,000 | +509.5% | 383,472 | +251.2% | 0.04% | +400.0% |
| Q1 2021 | $1,439,000 | – | 109,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |